163 results on '"Brouwers, Adrienne H."'
Search Results
2. Towards in vivo characterization of thyroid nodules suspicious for malignancy using multispectral optoacoustic tomography
3. Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry Calculations
4. Optimisation of scan duration and image quality in oncological 89Zr immunoPET imaging using the Biograph Vision PET/CT
5. Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial
6. Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)
7. EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data
8. Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy
9. Convolutional neural networks for automatic image quality control and EARL compliance of PET images
10. Shortened duration whole body 18F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function
11. [18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial
12. Advances and challenges in immunoPET methodology.
13. Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
14. Head-to-head comparison of [11C]methionine PET, [11C]choline PET, and 4-dimensional CT as second-line scans for detection of parathyroid adenomas in primary hyperparathyroidism.
15. The effects of molar activity on [18F]FDOPA uptake in patients with neuroendocrine tumors
16. A Novel and Generic Workflow of Indocyanine Green Perfusion Assessment Integrating Standardization and Quantification Toward Clinical Implementation
17. High rate of unexpected lymphatic drainage patterns and a high accuracy of the sentinel lymph node biopsy in oral cancer after previous neck treatment
18. Correlation between Histopathological Prognostic Tumor Characteristics and [ 18 F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer.
19. Ultra‐low dose CT scanning for PET/CT.
20. Comparison of 18F-DOPA Versus 68Ga-DOTATOC as Preferred PET Imaging Tracer in Well-Differentiated Neuroendocrine Neoplasms
21. Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
22. Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis
23. 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
24. NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk
25. Current and Future Use of Long Axial Field-of-View Positron Emission Tomography/Computed Tomography Scanners in Clinical Oncology.
26. Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for 89Zr-Trastuzumab.
27. The Diagnostic Value of 18F-FDG PET/CT Scan in Characterizing Adrenal Tumors.
28. Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT
29. Optimization of parathyroid 11C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism
30. Optimisation of scan duration and image quality in oncological 89Zr immunoPET imaging using the Biograph Vision PET/CT.
31. Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative 18F-FDG PET/CT analysis
32. Localization of parathyroid adenomas using 11C-methionine pet after prior inconclusive imaging
33. Volume of interest delineation techniques for 18F-FDG PET-CT scans during neoadjuvant extremity soft tissue sarcoma treatment in adults: a feasibility study
34. Lymphatic drainage patterns of oral maxillary tumors: Approachable locations of sentinel lymph nodes mainly at the cervical neck level
35. Additional value of a high sensitive thyroglobulin assay in the follow‐up of patients with differentiated thyroid carcinoma
36. Extending the clinical capabilities of short- and long-lived positron-emitting radionuclides through high sensitivity PET/CT.
37. Tailored imaging of islet cell tumors of the pancreas amidst increasing options
38. Shortened duration whole body 18F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function.
39. 89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
40. Progressive diastolic dysfunction in survivors of pediatric differentiated thyroid carcinoma.
41. Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy.
42. Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
43. Considerations on absence of 68Ga-DOTA-F(ab′)2-trastuzumab tracer uptake in HER2-overexpressing tumor lesions
44. [18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial.
45. Quality Indicators for the Diagnosis and Management of Primary Hyperparathyroidism.
46. Molecular imaging for monitoring treatment response in breast cancer patients
47. False positive spinal cord uptake on fluorodeoxyglucose positron-emission tomography following treatment of lymphoma
48. Low-Iodine Diet of 4 Days Is Sufficient Preparation for 131I Therapy in Differentiated Thyroid Cancer Patients.
49. Localization of an Adrenocorticotropin-Producing Pheochromocytoma Using 18F-Dihydroxyphenylalanine Positron Emission Tomography
50. Bone Mineral Density in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma: A Longitudinal Follow-Up Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.